BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Chapter

Reset

Active filters

Chemical substance: Afatinib

Presentation	Product	Chemical substance	Chapter	Items dispensed
Afatinib 20mg tablets 0801050BPAAACAC	Afatinib	Afatinib	Malignant Disease and Immunosuppression	No data available
Afatinib 30mg tablets 0801050BPAAAAAA	Afatinib	Afatinib	Malignant Disease and Immunosuppression	No data available
Afatinib 40mg tablets 0801050BPAAABAB	Afatinib	Afatinib	Malignant Disease and Immunosuppression	No data available
Afatinib 50mg tablets 0801050BPAAADAD	Afatinib	Afatinib	Malignant Disease and Immunosuppression	No data available
Gilotrif 20mg tablets 0801050BPBBACAC	Gilotrif	Afatinib	Malignant Disease and Immunosuppression	No data available
Gilotrif 30mg tablets 0801050BPBBAAAA	Gilotrif	Afatinib	Malignant Disease and Immunosuppression	No data available
Gilotrif 40mg tablets 0801050BPBBABAB	Gilotrif	Afatinib	Malignant Disease and Immunosuppression	No data available
Giotrif 20mg tablets 0801050BPBCAAAC	Giotrif	Afatinib	Malignant Disease and Immunosuppression	No data available
Giotrif 30mg tablets 0801050BPBCABAA	Giotrif	Afatinib	Malignant Disease and Immunosuppression	No data available
Giotrif 40mg tablets 0801050BPBCACAB	Giotrif	Afatinib	Malignant Disease and Immunosuppression	No data available
Giotrif 50mg tablets 0801050BPBCADAD	Giotrif	Afatinib	Malignant Disease and Immunosuppression	No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.